Singapore markets close in 3 hours 49 minutes
Straits Times Index
3,325.38 -0.90 (-0.03%) Nikkei
39,670.66 +497.51 (+1.27%) Hang Seng
18,069.75 -3.15 (-0.02%) FTSE 100
8,247.79 -33.76 (-0.41%) Bitcoin USD
61,749.81 +386.44 (+0.63%) CMC Crypto 200
1,280.48 +31.36 (+2.51%)
SANA Jul 2024 5.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:59PM EDT. Market open.
| Previous close | 1.3500 |
| Open | 1.2500 |
| Bid | 1.2500 |
| Ask | 1.4000 |
| Strike | 5.00 |
| Expiry date | 2024-07-19 |
| Day's range | 1.0000 - 1.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 5.14k |
GlobeNewswireSana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Glial-based Neurodegenerative Conditions
Healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin mice Additional proof-of-concept for the advancement of SC379, Sana’s pluripotent stem cell-derived glial progenitor cell product candidate SEATTLE, May 21, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today highlighted that Nature Biotechnology has published a paper titled “You
Simply Wall St.Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Invest In Growth?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
Sana Biotechnology Inc (SANA) Reports First Quarter 2024 Financial Results
Aligns with Analyst Projections Amidst Strategic Clinical Advancements
© 2024 Yahoo. All rights reserved.